Below you'll find information about our ongoing studies. Please let us know if you are interested in participating. The contact information for each study is listed along with the study descriptions below. If you would like to participate in a study, but do not know which you qualify for, please call our study staff at (415) 221-4810 ext 24117, or email [email protected]. Click here to learn about our Completed Studies.
PhROST (Pharmaco-Imaging Responses to Oxytocin in Schizophrenia)
A pharmaco-imaging approach to predicting social functioning and clinical responses to oxytocin administration in schizophrenia
This study aims to test whether oxytocin could be an effective treatment for social functioning deficits in schizophrenia. We will examine changes in brain activation to understand how oxytocin affects behavior and to predict which individuals may benefit from oxytocin treatment.
If you would like to participate as a patient, please call (415) 221-4810 ext 24117 or email [email protected] for more information.
Psilocybin for MDD: Behavioral
Effects of Psilocybin on cognition, neuroplasticity, and immune function in Major Depressive Disorder
This ancillary project will allow participants engaged in the parent study to optionally enroll in additional assessments and behavioral testing to gather data on learning, cognition, emotion, and immune function.
Psilocybin for MDD Study
A Randomized, Double-Blind, Support-of-Concept Phase 2 Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)
UCSF is one of seven research sites engaged with the study sponsor, USONA, to conduct this study and to potentially continue into Phase 3 testing.
MDMA for PTSD Study
A Study of the Safety and Effect of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder
This Phase 3 study is centered around understanding the underlying mechanisms through which MDMA coupled with psychotherapy may be useful for the treatment of PTSD.
Stimulant Oxytocin Study (SOS)
This study aims to examine the effects of oxytocin on stimulant use disorder and co-occuring opioid use disorder in Veteran populations.
We are currently looking for Veterans with cocaine use disorder who are enrolled as a patient at the SFVAMC Opioid Treatment Program. Participants must speak English fluently and be at least 18 years old.